EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights

Majid Iqbal iD, Qian Yu, Jingqun Tang iD, Juanjuan Xiang iD

Journal of Bacteriology · 2025

DOI: 10.1128/jb.00479-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Bacteriology, 2025. Verfasst von Majid Iqbal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Obesity, Bacteria. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural science foundation changsha, National Key Clinical Specialty Discipline Construction Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, characterized by excessive fat accumulation, stems from an imbalance between energy intake and expenditure, with the gut microbiota playing a crucial role. This review highlights how gut microbiota influences metabolic pathways, inflammation, and adipose tissue regulation in obesity. Specific bacteria and metabolites, such as lipopolysaccharides (LPS) and short-chain fatty acids (SCFAs), modulate gut permeability, inflammation, and energy harvest, impacting obesity development. Certain gut bacteria, including Clostridium XIVb , Dorea spp., Enterobacter cloacae , and Collinsella aerofaciens , promote obesity by increasing energy harvest, gut permeability, and inflammatory response through LPS translocation into the bloodstream. Conversely, beneficial bacteria like Akkermansia muciniphila , Lactobacillus spp., and Bifidobacterium spp. enhance gut barrier integrity, regulate SCFA production, and modulate fasting-induced adipose factor, which collectively support metabolic health by reducing fat storage and inflammation. Metabolites such as SCFAs (acetate, propionate, and butyrate) interact with G-protein coupled receptors to regulate lipid metabolism and promote the browning of white adipose tissue (WAT), thus enhancing thermogenesis and energy expenditure. However, LPS contributes to insulin resistance and fat accumulation, highlighting the dual roles of these microbial metabolites in both supporting and disrupting metabolic function. Therapeutic interventions targeting gut microbiota, such as promoting WAT browning and activating brown adipose tissue (BAT), hold promise for obesity management. However, personalized approaches are necessary due to individual microbiome variability. Further research is essential to translate these insights into microbiota-based clinical therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeObesityBacteriaHumansAnimalsFatty Acids, VolatileEnergy Metabolism

Stichwörter der Autor:innen

adipose tissuegut microbiotainflammationlipopolysaccharidesobesity

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital, Changsha, Hunan, China.
  • Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
  • NHC Key Laboratory of Carcinogenesis and the Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Majid Iqbal, Jingqun Tang, Juanjuan Xiang

Förderung

  • National Natural Science Foundation of China
  • Natural science foundation changsha
  • National Key Clinical Specialty Discipline Construction Program of China

Zitieren

APA

Iqbal, M., Yu, Q., Tang, J., & Xiang, J. (2025). Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights. Journal of Bacteriology. https://doi.org/10.1128/jb.00479-24

Vancouver

Iqbal M, Yu Q, Tang J, Xiang J. Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights. Journal of Bacteriology. 2025. doi:10.1128/jb.00479-24

BibTeX
@article{Iqbal2025,
  author = {Iqbal, Majid and Yu, Qian and Tang, Jingqun and Xiang, Juanjuan},
  title = {Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights},
  journal = {Journal of Bacteriology},
  year = {2025},
  doi = {10.1128/jb.00479-24}
}
Kostenlos starten →